These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 3399292

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC.
    N Engl J Med; 1993 Nov 18; 329(21):1524-30. PubMed ID: 8413475
    [Abstract] [Full Text] [Related]

  • 4. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
    Bradley JP, Bacharier LB, Bonfiglio J, Schechtman KB, Strunk R, Storch G, Castro M.
    Pediatrics; 2005 Jan 18; 115(1):e7-14. PubMed ID: 15629968
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Respiratory syncytial virus infections in children admitted to the intensive care unit.
    Van Steensel-Moll HA, Van der Voort E, Bos AP, Rothbarth PH, Neijens HJ.
    Pediatrie; 1989 Jan 18; 44(7):583-8. PubMed ID: 2812976
    [Abstract] [Full Text] [Related]

  • 8. Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.
    Lacaze-Masmonteil T, Rozé JC, Fauroux B, French Pediatricians' Group of Sunagis Patients' Name-Based Programs.
    Pediatr Pulmonol; 2002 Sep 18; 34(3):181-8. PubMed ID: 12203846
    [Abstract] [Full Text] [Related]

  • 9. The severity of respiratory syncytial virus bronchiolitis in young infants in the United Arab Emirates.
    Howidi M, Rajah J, Abushrar Z, Parsons H.
    J Trop Pediatr; 2007 Feb 18; 53(1):22-6. PubMed ID: 17008442
    [Abstract] [Full Text] [Related]

  • 10. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.
    Smith DW, Frankel LR, Mathers LH, Tang AT, Ariagno RL, Prober CG.
    N Engl J Med; 1991 Jul 04; 325(1):24-9. PubMed ID: 1904551
    [Abstract] [Full Text] [Related]

  • 11. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study.
    Bloemers BL, van Furth AM, Weijerman ME, Gemke RJ, Broers CJ, van den Ende K, Kimpen JL, Strengers JL, Bont LJ.
    Pediatrics; 2007 Oct 04; 120(4):e1076-81. PubMed ID: 17908728
    [Abstract] [Full Text] [Related]

  • 12. Early ribavirin treatment of respiratory syncytial viral infection in high-risk children.
    Groothuis JR, Woodin KA, Katz R, Robertson AD, McBride JT, Hall CB, McWilliams BC, Lauer BA.
    J Pediatr; 1990 Nov 04; 117(5):792-8. PubMed ID: 2231215
    [Abstract] [Full Text] [Related]

  • 13. Prediction of the duration of hospitalization in patients with respiratory syncytial virus infection: use of clinical parameters.
    McMillan JA, Tristram DA, Weiner LB, Higgins AP, Sandstrom C, Brandon R.
    Pediatrics; 1988 Jan 04; 81(1):22-6. PubMed ID: 3336593
    [Abstract] [Full Text] [Related]

  • 14. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
    Figueras-Aloy J, Carbonell-Estrany X, Quero-Jiménez J, Fernández-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I, Doménech-Martínez E, IRIS Study Group.
    Pediatr Infect Dis J; 2008 Sep 04; 27(9):788-93. PubMed ID: 18664927
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
    Lanari M, Giovannini M, Giuffré L, Marini A, Rondini G, Rossi GA, Merolla R, Zuccotti GV, Salvioli GP, Investigators R.A.DA.R. Study Group.
    Pediatr Pulmonol; 2002 Jun 04; 33(6):458-65. PubMed ID: 12001280
    [Abstract] [Full Text] [Related]

  • 16. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.
    Boyce TG, Mellen BG, Mitchel EF, Wright PF, Griffin MR.
    J Pediatr; 2000 Dec 04; 137(6):865-70. PubMed ID: 11113845
    [Abstract] [Full Text] [Related]

  • 17. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization.
    Weinberg GA, Hall CB, Iwane MK, Poehling KA, Edwards KM, Griffin MR, Staat MA, Curns AT, Erdman DD, Szilagyi PG, New Vaccine Surveillance Network.
    J Pediatr; 2009 May 04; 154(5):694-9. PubMed ID: 19159905
    [Abstract] [Full Text] [Related]

  • 18. Hospitalization for respiratory syncytial virus infection in young children: development of a clinical prediction rule.
    Rietveld E, Vergouwe Y, Steyerberg EW, Huysman MW, de Groot R, Moll HA, RSV Study Group Southwest Netherlands.
    Pediatr Infect Dis J; 2006 Mar 04; 25(3):201-7. PubMed ID: 16511380
    [Abstract] [Full Text] [Related]

  • 19. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants.
    Pediatrics; 1998 Sep 04; 102(3):531-7. PubMed ID: 9724660
    [Abstract] [Full Text] [Related]

  • 20. Severe respiratory syncytial virus bronchiolitis: epidemiologic variations associated with the initiation of palivizumab in severely premature infants with bronchopulmonary dysplasia.
    Grimaldi M, Gouyon B, Michaut F, Huet F, Gouyon JB, Burgundy Perinatal Network.
    Pediatr Infect Dis J; 2004 Dec 04; 23(12):1081-5. PubMed ID: 15626942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.